COMMUNIQUÉS West-GlobeNewswire

TLC and 3SBio Form Exclusive Partnership to Commercialize Two NanoX™ Products in Mainland China

04/03/2019 - 03:57

SOUTH SAN FRANCISCO, Calif., TAIWAN, SHEN YANG, China and HONG KONG, March 04, 2019 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (“TLC”)(Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company [...]

Get Answers to Your Dermatology Questions with a New Series from Excelin Medical Spa

04/03/2019 - 00:40

Dr. Victoria Negrete and the Excelin Medical Spa team welcome guests to live events exploring CoolSculpting, wrinkles, and more in March APPLETON, Wis., March 03, 2019 (GLOBE NEWSWIRE) -- With the understanding that [...]

Verrica Pharmaceuticals Presents Positive Results from Two Phase 3 Clinical Trials of VP-102 in Late-Breaking Oral Presentation at the 2019 American Academy of Dermatology Meeting

02/03/2019 - 23:10

– CAMP-1 and CAMP-2 trials of VP-102 for the treatment of molluscum contagiosum successfully met their primary endpoints – – Molluscum contagiosum is a highly contagious , significantly undertreated viral skin disease [...]

Principia Biopharma Announces Positive Data from Phase 2 Pemphigus Vulgaris Trial at 2019 American Academy of Dermatology Annual Meeting in Late-Breaking Presentation

02/03/2019 - 20:20

-- Reached primary endpoint of Control of Disease Activity at four weeks in 54 percent of patients on low dose corticosteroids -- -- Median Anti-DSG antibodies reduced by up to 65 percent with 12 weeks of treatment [...]

Tonix Pharmaceuticals Provides Update on Tonmya® for the Treatment of Posttraumatic Stress Disorder

01/03/2019 - 23:41

NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat [...]

Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 14, 2019

01/03/2019 - 23:33

RALEIGH, N.C., March 01, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation [...]

Microbot Medical Maintains 2019 Milestone Targets Following Recent Court Decision

01/03/2019 - 23:23

HINGHAM, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT) is maintaining its milestone targets for 2019 following the recently announced decision of the New York State Supreme Court to [...]

Akorn Comments on Favorable Court Order

01/03/2019 - 23:17

LAKE FOREST, Ill., March 01, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX) announced today that the Delaware Court of Chancery has denied a request by Fresenius Kabi AG to bring a fraud claim against Akorn. On [...]

Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

01/03/2019 - 22:51

EMERYVILLE, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has issued inducement awards to five new [...]

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/03/2019 - 22:45

BURLINGTON, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to five new employees for an aggregate of 19,250 shares of common stock [...]

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

01/03/2019 - 22:30

BOSTON, March 01, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

01/03/2019 - 22:15

CHICAGO, March 01, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]

Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2018 Financial Results and Business Updates

01/03/2019 - 22:01

CAMBRIDGE, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]

Tonix Pharmaceuticals Announces Share Repurchase Program

01/03/2019 - 22:00

NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) today announced that its Board of Directors has approved a share repurchase program pursuant to [...]

ICU Medical, Inc. to Present at the Raymond James 40th Annual Institutional Investors Conference

01/03/2019 - 20:10

SAN CLEMENTE, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]

Logan Boulet’s Parents, Toby & Bernadine Boulet, to Launch GREEN SHIRT DAY In Honour of “Logan Boulet Effect” and Organ Donation Awareness

01/03/2019 - 19:39

LETHBRIDGE, Alberta, March 01, 2019 (GLOBE NEWSWIRE) -- Toby and Bernadine Boulet will be hosting a Press Conference at Lethbridge City Hall, Lethbridge, AB to launch the inaugural Green Shirt Day , in memoriam and in [...]

Grant of Restricted Stock Units and Warrants to Employees in Genmab

01/03/2019 - 19:32

Company Announcement Copenhagen, Denmark; March 1, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 6,397 restricted stock units and 19,982 warrants to [...]

Major shareholder notification – Marathon Asset Management LLP

01/03/2019 - 18:42

GN Store Nord has received information that Marathon Asset Management LLP has decreased its holdings of GN shares from 5.0% to 4.97%. Marathon Asset Management LLP thereby holds less than 5% of the share capital and the [...]

MRI Interventions to Host Meetings at Roth Capital Conference on March 18

01/03/2019 - 18:26

IRVINE, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures for deep brain stimulation, ablation, [...]